Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team

Antti Luiro

Head of Nordic ER Development, Analyst

Antti Luiro portrait

Coverage

LeadDeskNightingale HealthLoihdeSpringvestAiforia TechnologiesQt Group

Latest content

ShowingAll content types

Nightingale expands its strategic partnership with Terveystalo

Analyst Comment 27.11.2025 klo 11.12 by Antti Luiro
Nightingale Health

Faron to draw additional 10 MEUR tranche from its convertible bond

Analyst Comment 25.11.2025 klo 11.33 by Antti Luiro
Faron Pharmaceuticals

Aiforia: Tightening the belt in preparation for the scaling phase

Research 19.11.2025 klo 15.16 by Antti Luiro, Frans-Mikael Rostedt
Aiforia Technologies

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
Create account

Nightingale strengthens its research offering through strategic partnership

Analyst Comment 05.11.2025 klo 16.59 by Antti Luiro, Antti Siltanen
Nightingale Health

Aiforia initiates change negotiation

Analyst Comment 31.10.2025 klo 16.12 by Antti Luiro, Frans-Mikael Rostedt
Aiforia Technologies

Aiforia strengthens its market position in France

Analyst Comment 27.10.2025 klo 17.44 by Antti Luiro, Frans-Mikael Rostedt
Aiforia Technologies

Aiforia's software has been deployed at Fimlab Laboratories in Finland

Analyst Comment 13.10.2025 klo 18.24 by Antti Luiro, Frans-Mikael Rostedt
Aiforia Technologies

Nightingale’s service expands again with a new risk prediction

Analyst Comment 26.09.2025 klo 10.16 by Antti Luiro
Nightingale Health

Nightingale 1-6'2025: Eyeing the next commercial breakthrough

Research 19.09.2025 klo 14.29 by Antti Luiro, Antti Siltanen
Nightingale Health

Nightingale's research business received a boost from its first major multiomics order

Analyst Comment 16.09.2025 klo 20.40 by Antti Luiro
Nightingale Health
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.